Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Dementia Drugs Market 2018, Forecast to 2023

July 2018 | 133 pages | ID: G9B212F4859EN
GlobalInfoResearch

Abstracts

Scope of the Report:

This report focuses on the Dementia Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Dementia Drugs is expected to grow at a CAGR of roughly 8.5% over the next five years, will reach 22700 million US$ in 2023, from 13900 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Eisai, Inc
• Janssen Pharmaceuticals, Inc
• Biogen Pharmaceuticals
• Forest Laboratories, Inc
• Eli Lilly and Company
• Novartis AG
• Sanofi S.A
• AstraZeneca GmbH
• F. Hoffmann-La Roche
• Merck & Co., Inc
• Valeant Pharmaceutical International
• Pfizer Inc
• Teva Pharmaceuticals Industries

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• MAO Inhibitors
• Cholinesterase Inhibitors
• Glutamate Inhibitors

Market Segment by Applications, can be divided into

• Hospital Pharmacies
• Retail Pharmacies
• Others

There are 15 Chapters to deeply display the global Dementia Drugs market.
Chapter 1, to describe Dementia Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Dementia Drugs, with sales, revenue, and price of Dementia Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Dementia Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Dementia Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Dementia Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Dementia Drugs Introduction
1.2 Market Analysis by Type
  1.2.1 MAO Inhibitors
  1.2.2 Cholinesterase Inhibitors
  1.2.3 Glutamate Inhibitors
1.3 Market Analysis by Applications
  1.3.1 Hospital Pharmacies
  1.3.2 Retail Pharmacies
  1.3.3 Others
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Eisai, Inc
  2.1.1 Business Overview
    2.1.1.1 Eisai, Inc Description
    2.1.1.2 Eisai, Inc Headquarter, Main Business and Finance Overview
  2.1.2 Eisai, Inc Dementia Drugs Product Introduction
    2.1.2.1 Dementia Drugs Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Dementia Drugs Product Information
  2.1.3 Eisai, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 Eisai, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global Eisai, Inc Dementia Drugs Market Share in 2017
2.2 Janssen Pharmaceuticals, Inc
  2.2.1 Business Overview
    2.2.1.1 Janssen Pharmaceuticals, Inc Description
    2.2.1.2 Janssen Pharmaceuticals, Inc Headquarter, Main Business and Finance Overview
  2.2.2 Janssen Pharmaceuticals, Inc Dementia Drugs Product Introduction
    2.2.2.1 Dementia Drugs Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Dementia Drugs Product Information
  2.2.3 Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Janssen Pharmaceuticals, Inc Dementia Drugs Market Share in 2017
2.3 Biogen Pharmaceuticals
  2.3.1 Business Overview
    2.3.1.1 Biogen Pharmaceuticals Description
    2.3.1.2 Biogen Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.3.2 Biogen Pharmaceuticals Dementia Drugs Product Introduction
    2.3.2.1 Dementia Drugs Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Dementia Drugs Product Information
  2.3.3 Biogen Pharmaceuticals Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Biogen Pharmaceuticals Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Biogen Pharmaceuticals Dementia Drugs Market Share in 2017
2.4 Forest Laboratories, Inc
  2.4.1 Business Overview
    2.4.1.1 Forest Laboratories, Inc Description
    2.4.1.2 Forest Laboratories, Inc Headquarter, Main Business and Finance Overview
  2.4.2 Forest Laboratories, Inc Dementia Drugs Product Introduction
    2.4.2.1 Dementia Drugs Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Dementia Drugs Product Information
  2.4.3 Forest Laboratories, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Forest Laboratories, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Forest Laboratories, Inc Dementia Drugs Market Share in 2017
2.5 Eli Lilly and Company
  2.5.1 Business Overview
    2.5.1.1 Eli Lilly and Company Description
    2.5.1.2 Eli Lilly and Company Headquarter, Main Business and Finance Overview
  2.5.2 Eli Lilly and Company Dementia Drugs Product Introduction
    2.5.2.1 Dementia Drugs Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Dementia Drugs Product Information
  2.5.3 Eli Lilly and Company Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 Eli Lilly and Company Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global Eli Lilly and Company Dementia Drugs Market Share in 2017
2.6 Novartis AG
  2.6.1 Business Overview
    2.6.1.1 Novartis AG Description
    2.6.1.2 Novartis AG Headquarter, Main Business and Finance Overview
  2.6.2 Novartis AG Dementia Drugs Product Introduction
    2.6.2.1 Dementia Drugs Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Dementia Drugs Product Information
  2.6.3 Novartis AG Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Novartis AG Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Novartis AG Dementia Drugs Market Share in 2017
2.7 Sanofi S.A
  2.7.1 Business Overview
    2.7.1.1 Sanofi S.A Description
    2.7.1.2 Sanofi S.A Headquarter, Main Business and Finance Overview
  2.7.2 Sanofi S.A Dementia Drugs Product Introduction
    2.7.2.1 Dementia Drugs Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Dementia Drugs Product Information
  2.7.3 Sanofi S.A Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Sanofi S.A Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Sanofi S.A Dementia Drugs Market Share in 2017
2.8 AstraZeneca GmbH
  2.8.1 Business Overview
    2.8.1.1 AstraZeneca GmbH Description
    2.8.1.2 AstraZeneca GmbH Headquarter, Main Business and Finance Overview
  2.8.2 AstraZeneca GmbH Dementia Drugs Product Introduction
    2.8.2.1 Dementia Drugs Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Dementia Drugs Product Information
  2.8.3 AstraZeneca GmbH Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 AstraZeneca GmbH Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global AstraZeneca GmbH Dementia Drugs Market Share in 2017
2.9 F. Hoffmann-La Roche
  2.9.1 Business Overview
    2.9.1.1 F. Hoffmann-La Roche Description
    2.9.1.2 F. Hoffmann-La Roche Headquarter, Main Business and Finance Overview
  2.9.2 F. Hoffmann-La Roche Dementia Drugs Product Introduction
    2.9.2.1 Dementia Drugs Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Dementia Drugs Product Information
  2.9.3 F. Hoffmann-La Roche Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.1 F. Hoffmann-La Roche Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Global F. Hoffmann-La Roche Dementia Drugs Market Share in 2017
2.10 Merck & Co., Inc
  2.10.1 Business Overview
    2.10.1.1 Merck & Co., Inc Description
    2.10.1.2 Merck & Co., Inc Headquarter, Main Business and Finance Overview
  2.10.2 Merck & Co., Inc Dementia Drugs Product Introduction
    2.10.2.1 Dementia Drugs Production Bases, Sales Regions and Major Competitors
    2.10.2.2 Dementia Drugs Product Information
  2.10.3 Merck & Co., Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.1 Merck & Co., Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 Global Merck & Co., Inc Dementia Drugs Market Share in 2017
2.11 Valeant Pharmaceutical International
  2.11.1 Business Overview
  2.11.2 Valeant Pharmaceutical International Dementia Drugs Product Introduction
  2.11.3 Valeant Pharmaceutical International Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Pfizer Inc
  2.12.1 Business Overview
  2.12.2 Pfizer Inc Dementia Drugs Product Introduction
  2.12.3 Pfizer Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Teva Pharmaceuticals Industries
  2.13.1 Business Overview
  2.13.2 Teva Pharmaceuticals Industries Dementia Drugs Product Introduction
  2.13.3 Teva Pharmaceuticals Industries Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL DEMENTIA DRUGS MARKET COMPETITION, BY MANUFACTURER

3.1 Global Dementia Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Dementia Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Dementia Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Dementia Drugs Manufacturer Market Share in 2017
  3.4.2 Top 5 Dementia Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL DEMENTIA DRUGS MARKET ANALYSIS BY REGIONS

4.1 Global Dementia Drugs Sales, Revenue and Market Share by Regions
  4.1.1 Global Dementia Drugs Sales by Regions (2013-2018)
  4.1.2 Global Dementia Drugs Revenue by Regions (2013-2018)
4.2 North America Dementia Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Dementia Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Dementia Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Dementia Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Dementia Drugs Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA DEMENTIA DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Dementia Drugs Sales, Revenue and Market Share by Countries
  5.1.1 North America Dementia Drugs Sales by Countries (2013-2018)
  5.1.2 North America Dementia Drugs Revenue by Countries (2013-2018)
  5.1.3 United States Dementia Drugs Sales and Growth Rate (2013-2018)
  5.1.4 Canada Dementia Drugs Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Dementia Drugs Sales and Growth Rate (2013-2018)
5.2 North America Dementia Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Dementia Drugs Sales by Manufacturers (2016-2017)
  5.2.2 North America Dementia Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Dementia Drugs Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Dementia Drugs Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Dementia Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Dementia Drugs Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Dementia Drugs Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Dementia Drugs Revenue and Revenue Share by Application (2013-2018)

6 EUROPE DEMENTIA DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Dementia Drugs Sales, Revenue and Market Share by Countries
  6.1.1 Europe Dementia Drugs Sales by Countries (2013-2018)
  6.1.2 Europe Dementia Drugs Revenue by Countries (2013-2018)
  6.1.3 Germany Dementia Drugs Sales and Growth Rate (2013-2018)
  6.1.4 UK Dementia Drugs Sales and Growth Rate (2013-2018)
  6.1.5 France Dementia Drugs Sales and Growth Rate (2013-2018)
  6.1.6 Russia Dementia Drugs Sales and Growth Rate (2013-2018)
  6.1.7 Italy Dementia Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Dementia Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Dementia Drugs Sales by Manufacturers (2016-2017)
  6.2.2 Europe Dementia Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Dementia Drugs Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Dementia Drugs Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Dementia Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Dementia Drugs Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Dementia Drugs Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Dementia Drugs Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC DEMENTIA DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Dementia Drugs Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Dementia Drugs Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Dementia Drugs Revenue by Countries (2013-2018)
  7.1.3 China Dementia Drugs Sales and Growth Rate (2013-2018)
  7.1.4 Japan Dementia Drugs Sales and Growth Rate (2013-2018)
  7.1.5 Korea Dementia Drugs Sales and Growth Rate (2013-2018)
  7.1.6 India Dementia Drugs Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Dementia Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Dementia Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Dementia Drugs Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Dementia Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Dementia Drugs Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Dementia Drugs Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Dementia Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Dementia Drugs Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Dementia Drugs Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Dementia Drugs Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA DEMENTIA DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Dementia Drugs Sales, Revenue and Market Share by Countries
  8.1.1 South America Dementia Drugs Sales by Countries (2013-2018)
  8.1.2 South America Dementia Drugs Revenue by Countries (2013-2018)
  8.1.3 Brazil Dementia Drugs Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Dementia Drugs Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Dementia Drugs Sales and Growth Rate (2013-2018)
8.2 South America Dementia Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Dementia Drugs Sales by Manufacturers (2016-2017)
  8.2.2 South America Dementia Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Dementia Drugs Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Dementia Drugs Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Dementia Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Dementia Drugs Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Dementia Drugs Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Dementia Drugs Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA DEMENTIA DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Dementia Drugs Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Dementia Drugs Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Dementia Drugs Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Dementia Drugs Sales and Growth Rate (2013-2018)
  9.1.4 UAE Dementia Drugs Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Dementia Drugs Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Dementia Drugs Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Dementia Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Dementia Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Dementia Drugs Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Dementia Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Dementia Drugs Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Dementia Drugs Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Dementia Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Dementia Drugs Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Dementia Drugs Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Dementia Drugs Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL DEMENTIA DRUGS MARKET SEGMENT BY TYPE

10.1 Global Dementia Drugs Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Dementia Drugs Sales and Market Share by Type (2013-2018)
  10.1.2 Global Dementia Drugs Revenue and Market Share by Type (2013-2018)
10.2 MAO Inhibitors Sales Growth and Price
  10.2.1 Global MAO Inhibitors Sales Growth (2013-2018)
  10.2.2 Global MAO Inhibitors Price (2013-2018)
10.3 Cholinesterase Inhibitors Sales Growth and Price
  10.3.1 Global Cholinesterase Inhibitors Sales Growth (2013-2018)
  10.3.2 Global Cholinesterase Inhibitors Price (2013-2018)
10.4 Glutamate Inhibitors Sales Growth and Price
  10.4.1 Global Glutamate Inhibitors Sales Growth (2013-2018)
  10.4.2 Global Glutamate Inhibitors Price (2013-2018)

11 GLOBAL DEMENTIA DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Dementia Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Retail Pharmacies Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)

12 DEMENTIA DRUGS MARKET FORECAST (2018-2023)

12.1 Global Dementia Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Dementia Drugs Market Forecast by Regions (2018-2023)
  12.2.1 North America Dementia Drugs Market Forecast (2018-2023)
  12.2.2 Europe Dementia Drugs Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Dementia Drugs Market Forecast (2018-2023)
  12.2.4 South America Dementia Drugs Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Dementia Drugs Market Forecast (2018-2023)
12.3 Dementia Drugs Market Forecast by Type (2018-2023)
  12.3.1 Global Dementia Drugs Sales Forecast by Type (2018-2023)
  12.3.2 Global Dementia Drugs Market Share Forecast by Type (2018-2023)
12.4 Dementia Drugs Market Forecast by Application (2018-2023)
  12.4.1 Global Dementia Drugs Sales Forecast by Application (2018-2023)
  12.4.2 Global Dementia Drugs Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Dementia Drugs Picture
Table Product Specifications of Dementia Drugs
Figure Global Dementia Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Dementia Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Dementia Drugs by Types in 2017
Figure MAO Inhibitors Picture
Table Major Manufacturers of MAO Inhibitors
Figure Cholinesterase Inhibitors Picture
Table Major Manufacturers of Cholinesterase Inhibitors
Figure Glutamate Inhibitors Picture
Table Major Manufacturers of Glutamate Inhibitors
Figure Dementia Drugs Sales Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Others Picture
Figure United States Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Dementia Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Eisai, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Eisai, Inc Dementia Drugs Production Bases, Sales Regions and Major Competitors
Table Eisai, Inc Dementia Drugs Product
Table Eisai, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eisai, Inc Dementia Drugs Sales Market Share in 2017
Figure Global Eisai, Inc Dementia Drugs Revenue Market Share in 2017
Table Janssen Pharmaceuticals, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Janssen Pharmaceuticals, Inc Dementia Drugs Production Bases, Sales Regions and Major Competitors
Table Janssen Pharmaceuticals, Inc Dementia Drugs Product
Table Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Janssen Pharmaceuticals, Inc Dementia Drugs Sales Market Share in 2017
Figure Global Janssen Pharmaceuticals, Inc Dementia Drugs Revenue Market Share in 2017
Table Biogen Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Biogen Pharmaceuticals Dementia Drugs Production Bases, Sales Regions and Major Competitors
Table Biogen Pharmaceuticals Dementia Drugs Product
Table Biogen Pharmaceuticals Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Biogen Pharmaceuticals Dementia Drugs Sales Market Share in 2017
Figure Global Biogen Pharmaceuticals Dementia Drugs Revenue Market Share in 2017
Table Forest Laboratories, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Forest Laboratories, Inc Dementia Drugs Production Bases, Sales Regions and Major Competitors
Table Forest Laboratories, Inc Dementia Drugs Product
Table Forest Laboratories, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Forest Laboratories, Inc Dementia Drugs Sales Market Share in 2017
Figure Global Forest Laboratories, Inc Dementia Drugs Revenue Market Share in 2017
Table Eli Lilly and Company Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly and Company Dementia Drugs Production Bases, Sales Regions and Major Competitors
Table Eli Lilly and Company Dementia Drugs Product
Table Eli Lilly and Company Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly and Company Dementia Drugs Sales Market Share in 2017
Figure Global Eli Lilly and Company Dementia Drugs Revenue Market Share in 2017
Table Novartis AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis AG Dementia Drugs Production Bases, Sales Regions and Major Competitors
Table Novartis AG Dementia Drugs Product
Table Novartis AG Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis AG Dementia Drugs Sales Market Share in 2017
Figure Global Novartis AG Dementia Drugs Revenue Market Share in 2017
Table Sanofi S.A Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi S.A Dementia Drugs Production Bases, Sales Regions and Major Competitors
Table Sanofi S.A Dementia Drugs Product
Table Sanofi S.A Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi S.A Dementia Drugs Sales Market Share in 2017
Figure Global Sanofi S.A Dementia Drugs Revenue Market Share in 2017
Table AstraZeneca GmbH Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca GmbH Dementia Drugs Production Bases, Sales Regions and Major Competitors
Table AstraZeneca GmbH Dementia Drugs Product
Table AstraZeneca GmbH Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca GmbH Dementia Drugs Sales Market Share in 2017
Figure Global AstraZeneca GmbH Dementia Drugs Revenue Market Share in 2017
Table F. Hoffmann-La Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table F. Hoffmann-La Roche Dementia Drugs Production Bases, Sales Regions and Major Competitors
Table F. Hoffmann-La Roche Dementia Drugs Product
Table F. Hoffmann-La Roche Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global F. Hoffmann-La Roche Dementia Drugs Sales Market Share in 2017
Figure Global F. Hoffmann-La Roche Dementia Drugs Revenue Market Share in 2017
Table Merck & Co., Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck & Co., Inc Dementia Drugs Production Bases, Sales Regions and Major Competitors
Table Merck & Co., Inc Dementia Drugs Product
Table Merck & Co., Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck & Co., Inc Dementia Drugs Sales Market Share in 2017
Figure Global Merck & Co., Inc Dementia Drugs Revenue Market Share in 2017
Table Valeant Pharmaceutical International
Table Valeant Pharmaceutical International Dementia Drugs
Table Pfizer Inc
Table Pfizer Inc Dementia Drugs
Table Teva Pharmaceuticals Industries
Table Teva Pharmaceuticals Industries Dementia Drugs
Table Global Dementia Drugs Sales by Manufacturer (2016-2017)
Figure Global Dementia Drugs Sales Market Share by Manufacturer in 2016
Figure Global Dementia Drugs Sales Market Share by Manufacturer in 2017
Table Global Dementia Drugs Revenue by Manufacturer (2016-2017)
Figure Global Dementia Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Dementia Drugs Revenue Market Share by Manufacturer in 2017
Table Global Dementia Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Dementia Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Dementia Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Global Dementia Drugs Revenue and Growth Rate (2013-2018)
Table Global Dementia Drugs Sales by Regions (2013-2018)
Table Global Dementia Drugs Sales Market Share by Regions (2013-2018)
Table Global Dementia Drugs Revenue by Regions (2013-2018)
Figure Global Dementia Drugs Revenue Market Share by Regions in 2013
Figure Global Dementia Drugs Revenue Market Share by Regions in 2017
Figure North America Dementia Drugs Sales and Growth Rate (2013-2018)
Figure North America Dementia Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Europe Dementia Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Dementia Drugs Revenue and Growth Rate (2013-2018)
Figure South America Dementia Drugs Sales and Growth Rate (2013-2018)
Figure South America Dementia Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Dementia Drugs Revenue and Growth Rate (2013-2018)
Figure North America Dementia Drugs Revenue and Growth Rate (2013-2018)
Table North America Dementia Drugs Sales by Countries (2013-2018)
Table North America Dementia Drugs Sales Market Share by Countries (2013-2018)
Figure North America Dementia Drugs Sales Market Share by Countries in 2013
Figure North America Dementia Drugs Sales Market Share by Countries in 2017
Table North America Dementia Drugs Revenue by Countries (2013-2018)
Table North America Dementia Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Dementia Drugs Revenue Market Share by Countries in 2013
Figure North America Dementia Drugs Revenue Market Share by Countries in 2017
Figure United States Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Canada Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Dementia Drugs Sales and Growth Rate (2013-2018)
Table North America Dementia Drugs Sales by Manufacturer (2016-2017)
Figure North America Dementia Drugs Sales Market Share by Manufacturer in 2016
Figure North America Dementia Drugs Sales Market Share by Manufacturer in 2017
Table North America Dementia Drugs Revenue by Manufacturer (2016-2017)
Figure North America Dementia Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Dementia Drugs Revenue Market Share by Manufacturer in 2017
Table North America Dementia Drugs Sales by Type (2013-2018)
Table North America Dementia Drugs Sales Share by Type (2013-2018)
Table North America Dementia Drugs Revenue by Type (2013-2018)
Table North America Dementia Drugs Revenue Share by Type (2013-2018)
Table North America Dementia Drugs Sales by Application (2013-2018)
Table North America Dementia Drugs Sales Share by Application (2013-2018)
Table North America Dementia Drugs Revenue by Application (2013-2018)
Table North America Dementia Drugs Revenue Share by Application (2013-2018)
Figure Europe Dementia Drugs Revenue and Growth Rate (2013-2018)
Table Europe Dementia Drugs Sales by Countries (2013-2018)
Table Europe Dementia Drugs Sales Market Share by Countries (2013-2018)
Table Europe Dementia Drugs Revenue by Countries (2013-2018)
Figure Europe Dementia Drugs Revenue Market Share by Countries in 2016
Figure Europe Dementia Drugs Revenue Market Share by Countries in 2017
Figure Germany Dementia Drugs Sales and Growth Rate (2013-2018)
Figure UK Dementia Drugs Sales and Growth Rate (2013-2018)
Figure France Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Russia Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Italy Dementia Drugs Sales and Growth Rate (2013-2018)
Table Europe Dementia Drugs Sales by Manufacturer (2016-2017)
Figure Europe Dementia Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Dementia Drugs Sales Market Share by Manufacturer in 2017
Table Europe Dementia Drugs Revenue by Manufacturer (2016-2017)
Figure Europe Dementia Drugs Revenue Market Share by Manufacturer in 2016
Figure Europe Dementia Drugs Revenue Market Share by Manufacturer in 2017
Table Europe Dementia Drugs Sales by Type (2013-2018)
Table Europe Dementia Drugs Sales Share by Type (2013-2018)
Table Europe Dementia Drugs Revenue by Type (2013-2018)
Table Europe Dementia Drugs Revenue Share by Type (2013-2018)
Table Europe Dementia Drugs Sales by Application (2013-2018)
Table Europe Dementia Drugs Sales Share by Application (2013-2018)
Table Europe Dementia Drugs Revenue by Application (2013-2018)
Table Europe Dementia Drugs Revenue Share by Application (2013-2018)
Figure Asia-Pacific Dementia Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Dementia Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Dementia Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Dementia Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Dementia Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Dementia Drugs Revenue Market Share by Countries 2017
Figure China Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Japan Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Korea Dementia Drugs Sales and Growth Rate (2013-2018)
Figure India Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Dementia Drugs Sales and Growth Rate (2013-2018)
Table Asia-Pacific Dementia Drugs Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Dementia Drugs Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Dementia Drugs Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Dementia Drugs Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Dementia Drugs Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Dementia Drugs Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Dementia Drugs Sales by Type (2013-2018)
Table Asia-Pacific Dementia Drugs Sales Share by Type (2013-2018)
Table Asia-Pacific Dementia Drugs Revenue by Type (2013-2018)
Table Asia-Pacific Dementia Drugs Revenue Share by Type (2013-2018)
Table Asia-Pacific Dementia Drugs Sales by Application (2013-2018)
Table Asia-Pacific Dementia Drugs Sales Share by Application (2013-2018)
Table Asia-Pacific Dementia Drugs Revenue by Application (2013-2018)
Table Asia-Pacific Dementia Drugs Revenue Share by Application (2013-2018)
Figure South America Dementia Drugs Revenue and Growth Rate (2013-2018)
Table South America Dementia Drugs Sales by Countries (2013-2018)
Table South America Dementia Drugs Sales Market Share by Countries (2013-2018)
Figure South America Dementia Drugs Sales Market Share by Countries in 2017
Table South America Dementia Drugs Revenue by Countries (2013-2018)
Table South America Dementia Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Dementia Drugs Revenue Market Share by Countries in 2017
Figure Brazil Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Dementia Drugs Sales and Growth Rate (2013-2018)
Table South America Dementia Drugs Sales by Manufacturer (2016-2017)
Figure South America Dementia Drugs Sales Market Share by Manufacturer in 2016
Figure South America Dementia Drugs Sales Market Share by Manufacturer in 2017
Table South America Dementia Drugs Revenue by Manufacturer (2016-2017)
Figure South America Dementia Drugs Revenue Market Share by Manufacturer in 2016
Figure South America Dementia Drugs Revenue Market Share by Manufacturer in 2017
Table South America Dementia Drugs Sales by Type (2013-2018)
Table South America Dementia Drugs Sales Share by Type (2013-2018)
Table South America Dementia Drugs Revenue by Type (2013-2018)
Table South America Dementia Drugs Revenue Share by Type (2013-2018)
Table South America Dementia Drugs Sales by Application (2013-2018)
Table South America Dementia Drugs Sales Share by Application (2013-2018)
Table South America Dementia Drugs Revenue by Application (2013-2018)
Table South America Dementia Drugs Revenue Share by Application (2013-2018)
Figure Middle East and Africa Dementia Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Dementia Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Dementia Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Dementia Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Dementia Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Dementia Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Dementia Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Dementia Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Dementia Drugs Sales and Growth Rate (2013-2018)
Figure UAE Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Dementia Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Dementia Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Dementia Drugs Sales and Growth Rate (2013-2018)
Table Middle East and Africa Dementia Drugs Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Dementia Drugs Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Dementia Drugs Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Dementia Drugs Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Dementia Drugs Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Dementia Drugs Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Dementia Drugs Sales by Type (2013-2018)
Table Middle East and Africa Dementia Drugs Sales Share by Type (2013-2018)
Table Middle East and Africa Dementia Drugs Revenue by Type (2013-2018)
Table Middle East and Africa Dementia Drugs Revenue Share by Type (2013-2018)
Table Middle East and Africa Dementia Drugs Sales by Application (2013-2018)
Table Middle East and Africa Dementia Drugs Sales Share by Application (2013-2018)
Table Middle East and Africa Dementia Drugs Revenue by Application (2013-2018)
Table Middle East and Africa Dementia Drugs Revenue Share by Application (2013-2018)
Table Global Dementia Drugs Sales by Type (2013-2018)
Table Global Dementia Drugs Sales Share by Type (2013-2018)
Table Global Dementia Drugs Revenue by Type (2013-2018)
Table Global Dementia Drugs Revenue Share by Type (2013-2018)
Figure Global MAO Inhibitors Sales Growth (2013-2018)
Figure Global MAO Inhibitors Price (2013-2018)
Figure Global Cholinesterase Inhibitors Sales Growth (2013-2018)
Figure Global Cholinesterase Inhibitors Price (2013-2018)
Figure Global Glutamate Inhibitors Sales Growth (2013-2018)
Figure Global Glutamate Inhibitors Price (2013-2018)
Table Global Dementia Drugs Sales by Application (2013-2018)
Table Global Dementia Drugs Sales Share by Application (2013-2018)
Figure Global Hospital Pharmacies Sales Growth (2013-2018)
Figure Global Retail Pharmacies Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Dementia Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Dementia Drugs Sales Forecast by Regions (2018-2023)
Table Global Dementia Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Dementia Drugs Market Forecast (2018-2023)
Figure Europe Sales Dementia Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Dementia Drugs Market Forecast (2018-2023)
Figure South America Sales Dementia Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Dementia Drugs Market Forecast (2018-2023)
Table Global Dementia Drugs Sales Forecast by Type (2018-2023)
Table Global Dementia Drugs Market Share Forecast by Type (2018-2023)
Table Global Dementia Drugs Sales Forecast by Application (2018-2023)
Table Global Dementia Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List